Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Seres Therapeutics (MCRB)
Technical Analysis Report for NASDAQ stock MCRB Seres Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics then click here. or read Experts views on Seres Therapeutics or Forecast & share price targets of Seres Therapeutics
Seres Therapeutics Opened at 13.50 and Closed at: 13.96, which is 4.01% of previous session's close. It moved within a range of 13.50 and 14.32
The session was a Bullish session with an average volume of 63800, which is -17.55% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
Support for tomorrow is 13.73 and resistance for tomorrow is 14.55
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 13.53, 13.11 resistance for tomorrow's hourly charts is 14.35, 14.75
10 Day SMA for Seres Therapeutics (MCRB) is 14.8 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Seres Therapeutics (MCRB) is 15.16 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Seres Therapeutics (MCRB) is 15.7 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 16.97 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Seres Therapeutics is 14.48 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Seres Therapeutics is at 15.16 and 200 DMA is at 14.48, while 50 DMA and 100 DMA are at 15.7 and 16.97 respectively
Seres Therapeutics (MCRB) moving average of 20 SMA is at 15.16 and 20 EMA is at 14.95
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 13.96 | 15.16 | 14.95 |
| 05 Thu Feb | 13.40 | 15.23 | 15.05 |
| 04 Wed Feb | 13.63 | 15.35 | 15.22 |
| 03 Tue Feb | 15.40 | 15.45 | 15.39 |
| 02 Mon Feb | 15.15 | 15.44 | 15.39 |
| 30 Fri Jan | 14.92 | 15.44 | 15.42 |
Seres Therapeutics (MCRB) moving average of 50 SMA is at 15.7 and 50 EMA is at 15.64
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 13.96 | 15.7 | 15.64 |
| 05 Thu Feb | 13.40 | 15.76 | 15.71 |
| 04 Wed Feb | 13.63 | 15.84 | 15.8 |
| 03 Tue Feb | 15.40 | 16 | 15.89 |
| 02 Mon Feb | 15.15 | 16.27 | 15.91 |
| 30 Fri Jan | 14.92 | 16.46 | 15.94 |
Seres Therapeutics (MCRB) moving average of 100 SMA is at 16.97 and 100 EMA is at 15.7
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 13.96 | 16.97 | 15.7 |
| 05 Thu Feb | 13.40 | 16.99 | 15.74 |
| 04 Wed Feb | 13.63 | 17.01 | 15.79 |
| 03 Tue Feb | 15.40 | 17.05 | 15.83 |
| 02 Mon Feb | 15.15 | 17.08 | 15.84 |
| 30 Fri Jan | 14.92 | 17.11 | 15.85 |
Seres Therapeutics (MCRB) moving average of 200 SMA is at 14.48 and 200 EMA is at 13.69
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 13.96 | 14.48 | 13.69 |
| 05 Thu Feb | 13.40 | 14.41 | 13.69 |
| 04 Wed Feb | 13.63 | 14.35 | 13.69 |
| 03 Tue Feb | 15.40 | 14.28 | 13.69 |
| 02 Mon Feb | 15.15 | 14.21 | 13.67 |
| 30 Fri Jan | 14.92 | 14.13 | 13.66 |
Dentsply Sirona has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 18.38% more returns!
Tiziana Life has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 5.9% more returns!
Seres Therapeutics has performed better than Insulet Corporation in short term. Holding Seres Therapeutics could be a better choice for now!
Nektar Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 3.5% more returns!
Merit Medical has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 6.31% more returns!
Masimo Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Masimo Corporation, about 10.97% more returns!
Seres Therapeutics has performed better than Arbutus Biopharma in short term. Holding Seres Therapeutics could be a better choice for now!
Seres Therapeutics has performed better than Aceto Corporation in short term. Holding Seres Therapeutics could be a better choice for now!
Aldeyra Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 45.35% more returns!
Seres Therapeutics has performed better than Aptevo Therapeutics in short term. Holding Seres Therapeutics could be a better choice for now!
Seres Therapeutics has performed better than Autolus Therapeutics in short term. Holding Seres Therapeutics could be a better choice for now!
Cerus Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Cerus Corporation, about 18.12% more returns!
Corvus Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 212.57% more returns!
Champions Oncology has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 7.27% more returns!
Edap Tms has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Edap Tms, about 39.33% more returns!
Seres Therapeutics has performed better than Fortress Biotech in short term. Holding Seres Therapeutics could be a better choice for now!
Seres Therapeutics has performed better than Galectin Therapeutics in short term. Holding Seres Therapeutics could be a better choice for now!
Iterum Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Iterum Therapeutics, about 1.71% more returns!
Jazz Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 13.51% more returns!
Seres Therapeutics Technical analysis of indicators
Price action analysis of Seres Therapeutics (MCRB) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Seres Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Seres Therapeutics in short term and the sell signal is strong.
Seres Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Seres Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Seres Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.32 and Seres Therapeutics MCRB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Seres Therapeutics MCRB stock. Volume based technical analysis of Seres Therapeutics MCRB stock is negative.
Seres Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MCRB Experts View which covers a lot of information including buying and selling signals
MCRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Seres Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


